Subscribe To
Mineralys Therapeutics Announces Pricing of Upsized Initial Public Offering
RADNOR, Pa., Feb. 09, 2023 (GLOBE NEWSWIRE) — Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone, today announced the pricing of its upsized initial public offering of 12,000,000 shares of common stock at an initial public offering price of $16.00 per share. All of […] The post Mineralys Therapeutics Announces Pricing of Upsized Initial Public Offering appeared first...
Read More
Posted: Feb 9 2023, 23:34
Author Name: forextv
Views: 110518